Vascularized composite allograft tolerance across MHC barriers in a large animal model

American Journal of Transplantation

Volumn 14, Issue 2, 2014, Pages 343-355

  Leonard, D A ^a,b   Kurtz, J M ^a,c   Mallard, C ^a   Albritton, A ^a   Duran Struuck, R ^a   Farkash, E A ^a   Crepeau, R ^a   Matar, A ^a   Horner, B M ^a   Randolph, M A ^a   Sachs, D H ^a   Huang, C A ^a   Cetrulo, C L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c EMMANUEL COLLEGE   (United States)

Author keywords

Miniature swine; mixed chimerism; skin transplant tolerance; vascularized composite allograft

Indexed keywords

CD3 IMMUNOTOXIN; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOTOXIN; INTERLEUKIN 2; INTERLEUKIN 3; METHYLPREDNISOLONE; STEM CELL FACTOR; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MINIPIG; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLIT THICKNESS SKIN GRAFT; T CELL DEPLETION; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; WHOLE BODY RADIATION; ANIMAL; COMPOSITE GRAFT; ENZYME IMMUNOASSAY; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; SWINE; TRANSPLANTATION TOLERANCE;

ANIMALS; COMPOSITE TISSUE ALLOGRAFTS; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; SWINE; SWINE, MINIATURE; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

EID: 84895062978     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12560     Document Type: Article

References (46)

1. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2010; 90: 1590-1594.
2. Fattah A, Cypel T, Donner EJ, Wang F, Alman BA, Zuker RM., The first successful lower extremity transplantation: 6-Year follow-up and implications for cortical plasticity. Am J Transplant 2011; 11: 2762-2767.
3. Strome M, Stein J, Esclamado R, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med 2001; 344: 1676-1679.
4. Levi DM, Tzakis AG, Kato T, et al. Transplantation of the abdominal wall. Lancet 2003; 361: 2173-2176.
5. Petruzzo P, Dubernard JM., The international registry on hand and composite tissue allotransplantation. Clin Transpl 2011; 247-253.
6. Morris P, Bradley A, Doyal L, et al. Face transplantation: A review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation 2007; 83: 109-128.
7. Petruzzo P, Kanitakis J, Badet L, et al. Long-term follow-up in composite tissue allotransplantation: In-depth study of five (hand and face) recipients. Am J Transplant 2011; 11: 808-816.
8. Kaufman CL, Ouseph R, Blair B, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant 2012; 12: 1004-1016.
9. Gordon CR, Avery RK, Abouhassan W, Siemionow M., Cytomegalovirus and other infectious issues related to face transplantation: Specific considerations, lessons learned, and future recommendations. Plast Reconstr Surg 2011; 127: 1515-1523.
10. Sachs DH., Tolerance: Of mice and men. J Clin Invest 2003; 111: 1819-1821.
11. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256-262.
12. Horner BM, Cina RA, Wikiel KJ, et al. Predictors of organ allograft tolerance following hematopoietic cell transplantation. Am J Transplant 2006; 6: 2894-2902.
13. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4: 124ra28.
14. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
15. Murray JE., Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg 1971; 47: 425-431.
16. Mathes DW, Hwang B, Graves SS, et al. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Transplantation 2011; 92: 1301-1308.
17. Kuo YR, Goto S, Shih HS, et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 2009; 87: 1769-1777.
18. Mathes DW, Randolph MA, Solari MG, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003; 75: 25-31.
19. Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004; 77: 514-521.
20. Cina RA, Wikiel KJ, Lee PW, et al. Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation 2006; 81: 1677-1685.
21. Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM Jr, Sachs DH., Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000; 105: 173-181.
22. Sykes M., Mixed chimerism and transplant tolerance. Immunity 2001; 14: 417-424.
23. Lunney JK, Sachs DH., Transplantation in miniature swine. V. Characterization of Ia antigens. J Immunol 1979; 122: 623-627.
24. Fuchimoto Y, Huang CA, Shimizu A, Seebach J, Arn JS, Sachs DH., An allelic non-histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs. Tissue Antigens 1999; 54: 43-52.
25. Huang CA, Yamada K, Murphy MC, et al. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9. Transplantation 1999; 68: 855-860.
26. Wang Z, Duran-Struuck R, Crepeau R, et al. Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin. Bioconjug Chem 2011; 22: 2014-2020.
27. Horner BM, Randolph MA, Duran-Struuck R, et al. Induction of tolerance to an allogeneic skin flap transplant in a preclinical large animal model. Transplant Proc 2009; 41: 539-541.
28. Pescovitz MD, Lunney JK, Sachs DH., Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol 1984; 133: 368-375.
29. Huang CA, Lorf T, Arn JS, Koo GC, Blake T, Sachs DH., Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplant 1999; 5: 201-212.
30. Jonjic S, Koszinowski UH., Monoclonal antibodies reactive with swine lymphocytes. I. Antibodies to membrane structures that define the cytolytic T lymphocyte subset in the swine. J Immunol 1984; 133: 647-652.
31. Halloran PJ, Sweeney SE, Strohmeier CM, Kim YB., Molecular cloning and identification of the porcine cytolytic trigger molecule G7 as a Fc gamma RIII alpha (CD16) homologue. J Immunol 1994; 153: 2631-2641.
32. Denham S, Shimizu M, Bianchi AT, Zwart RJ, Carr MM, Parkhouse RM., Monoclonal antibodies recognising differentiation antigens on porcine B cells. Vet Immunol Immunopathol 1994; 43: 259-267.
33. Lima B, Gleit ZL, Cameron AM, et al. Engraftment of quiescent progenitors and conversion to full chimerism following nonmyelosuppressive conditioning and hematopoietic cell transplantation in miniature swine. Biol Blood Marrow Transplant 2003; 9: 571-582.
34. Thistlethwaite JR Jr, Auchincloss H Jr, Pescovitz MD, Sachs DH., Immunologic characterization of MHC recombinant swine: Role of Class I and II antigens in in vitro immune responses. J Immunogenet 1984; 11: 9-19.
35. Leight GS, Sachs DH, Rosenberg SA., Transplantation in miniature swine. II. In vitro parameters of histocompatibility in MSLA homozygous minipigs. Transplantation 1977; 23: 271-276.
36. Jagasia M, Arora M, Flowers ME, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012; 119: 296-307.
37. Jenkins MK, Schwartz RH., Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987; 165: 302-319.
38. Gibson T, Medawar PB., The fate of skin homografts in man. J Anat 1943; 77: 299-310.
39. Medawar PB., The behaviour and fate of skin autografts and skin homografts in rabbits: A report to the War Wounds Committee of the Medical Research Council. J Anat 1944; 78: 176-199.
40. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ., Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401-411.
41. Wekerle T, Blaha P, Koporc Z, Bigenzahn S, Pusch M, Muehlbacher F., Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: Central versus peripheral tolerance. Transplantation 2003; 75: 21S-25S.
42. Sachs DH, Sykes M, Kawai T, Cosimi AB., Immuno-intervention for the induction of transplantation tolerance through mixed chimerism. Semin Immunol 2011; 23: 165-173.
43. Clark RA, Watanabe R, Teague JE, et al. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med 2012; 4: 117ra7.
44. + T (RM) cells providing global skin immunity. Nature 2012; 483: 227-231.
45. Seneschal J, Clark RA, Gehad A, Baecher-Allan CM, Kupper TS., Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 2012; 36: 873-884.
46. Eljaafari A, Badet L, Kanitakis J, et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation 2006; 82: 1764-1768.